That’s the norm @Asimpletonne,
We all know what we do, DYOR research blah blah. Biotechs are solely on fundamentals don’t you agree? IMU remain in the excellent dept in my eyes. They will be under the radar now more than ever in Big Pharma. So let ANNs be picked to shreds, Results are just that...great ANN.
From the website 17/12, page-49
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 4.0¢ | 3.8¢ | $375.7K | 9.729M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1863152 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 1212919 | 11 |
View Market Depth
| Last trade - 16.10pm 03/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
